Patent application number | Description | Published |
20100166884 | POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO [1, 2-A] PYRIDINE-3-YL-2,5-DIOXO-IH-PYRROL-3-YL)-9-FLUORO-1,2,3,4 TETRAHYDRO -2-(1-PIPERIDINYL-CARBONYL)-PYRROLO [3,2,1-JK] [1,4] BENZODIAZEPINE - A method for treating gastric cancer, ovarian cancer, non-small cell lung cancer, or colorectal cancer in a patient is described, as well as pharmaceutical compositions comprising 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-IH-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo[3,2,1-jk][1,4]benzodiazepine, useful for the method and a process for preparing said compositions. | 07-01-2010 |
20100260754 | DKK-1 ANTIBODIES - The invention provides human engineered antibodies, antigen-binding fragments thereof, that bind to, and inhibit the activity of, human DKK-1, and which are effective in treating diseases in which pathogenesis is mediated by DKK-1. | 10-14-2010 |
20100261712 | HEMATOPOIETIC NEOPLASM CHEMOTHERAPY - A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder, or non-MLL based acute lymphoid leukemia is provided. | 10-14-2010 |
20130039996 | POTENTIATION OF CANCER CHEMOTHERAPY BY 7-(2, 5- DIHYDRO- 4-IMIDAZO [1, 2-A] PYRIDINE-3-YL-2,5-DIOXO-IH-PYRROL-3-YL)-9-FLUORO-1,2,3,4 TETRAHYDRO -2-(1-PIPERIDINYL-CARBONYL)-PYRROLO [3,2,1-JK] [1,4] BENZODIAZEPINE - An improved method for treating gastric cancer, ovarian cancer, non-small cell lung cancer, or colorectal cancer in a patient is described, as well as pharmaceutical compositions useful for the method and a process for preparing said compositions. | 02-14-2013 |
20140235621 | HEMATOPOIETIC NEOPLASM CHEMOTHERAPY - A method and medicament for treating mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder, or non-MLL based acute lymphoid leukemia is provided. | 08-21-2014 |
Patent application number | Description | Published |
20110033361 | METHOD FOR REMOVING HALOGEN FROM LIQUID AMMONIA - The present invention relates to a method for depleting halide ions from liquid ammonia, wherein the liquid ammonia is brought into contact with a strongly basic ion exchanger, where the basic structure of the strongly basic ion exchanger is a covalently crosslinked polymer matrix. Furthermore, the present invention relates to the use of an ammonia obtainable according to the invention as starting material in the production of amines. | 02-10-2011 |
20110288337 | PROCESS FOR PREPARING 2-(2-TERT-BUTYLAMINOETHOXY)ETHANOL (TERT-BUTYLAMINODIGLYCOL, TBADG) - A process for preparing 2-(2-tert-butylaminoethoxy)ethanol (tert-butylaminodiglycol, TBADG) by reacting diethylene glycol (DG) with tert-butylamine (TBA) in the presence of hydrogen and of a copper catalyst, by effecting the reaction at a temperature in the range from 160 to 220° C. in the presence of a copper- and aluminum oxide-containing catalyst, where the catalytically active material of the catalyst, before the reduction thereof with hydrogen, comprises
| 11-24-2011 |
20120157715 | PROCESS FOR PREPARING AN N,N-DIALKY-ETHANOLAMINE HAVING HIGH COLOR STABILITY - A process for preparing an N,N-dialkylethanolamine of the formula I having high color stability | 06-21-2012 |
20130158294 | PROCESS FOR THE PREPARATION OF RACEMIC ALPHA-AMINO ACIDS - Process for the preparation of racemic α-amino acids or of glycine, wherein the corresponding α-hydroxycarboxylic acid, selected from hydroxyacetic acid, lactic acid, malic acid, α-hydroxyglutamic acid, isocitric acid, tartronic acid and tartaric acid, or at least one salt of the corresponding α-hydroxycarboxylic acid is reacted in the presence of at least one heterogeneous catalyst which comprises at least one transition metal, in the presence of hydrogen with at least one nitrogen compound (c), where the nitrogen compound (c) is selected from primary and secondary amines and ammonia. | 06-20-2013 |
20130324731 | PROCESS FOR THE PREPARATION OF A MONO-N-ALKYLPIPERAZINE - Process for the preparation of a mono-N-alkylpiperazine of the formula I | 12-05-2013 |
20130324732 | Process for the Preparation of a Mono-N-Alkypiperazine - Process for the preparation of a mono-N-alkylpiperazine of the formula I | 12-05-2013 |
20130331573 | Process for Preparing Piperazine - Process for preparing piperazine of the formula I | 12-12-2013 |
20130331574 | Process for Preparing Piperazine - Process for preparing piperazine of the formula I | 12-12-2013 |
20140018547 | Process for Preparing Pyrrolidine - Process for preparing pyrrolidine of the formula I | 01-16-2014 |